140 related articles for article (PubMed ID: 29219053)
1. Triazolopyrimidines and Thiazolopyrimidines: Synthesis, Anti-HSV-1, Cytotoxicity and Mechanism of Action.
Mohamed SF; Abbas EMH; Khalaf HS; Farghaly TA; Abd El-Shafy DN
Mini Rev Med Chem; 2018; 18(9):794-802. PubMed ID: 29219053
[TBL] [Abstract][Full Text] [Related]
2. Anti-HSV-1 activity and mechanism of action of some new synthesized substituted pyrimidine, thiopyrimidine and thiazolopyrimidine derivatives.
Mohamed SF; Flefel EM; Amr Ael-G; Abd El-Shafy DN
Eur J Med Chem; 2010 Apr; 45(4):1494-501. PubMed ID: 20110135
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, DNA-binding, and antiviral activity of certain pyrazolo[3,4-d]pyrimidine derivatives.
el-Bendary ER; Badria FA
Arch Pharm (Weinheim); 2000 Apr; 333(4):99-103. PubMed ID: 10816902
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral screening of some thieno[2,3-d]pyrimidine nucleosides.
Rashad AE; Ali MA
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):17-28. PubMed ID: 16440982
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives.
Jordão AK; Ferreira VF; Souza TM; Faria GG; Machado V; Abrantes JL; de Souza MC; Cunha AC
Bioorg Med Chem; 2011 Mar; 19(6):1860-5. PubMed ID: 21376603
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of C3-arylated-3-deazauridine derivatives with potent anti-HSV-1 activities.
Lalut J; Tripoteau L; Marty C; Bares H; Bourgougnon N; Felpin FX
Bioorg Med Chem Lett; 2012 Dec; 22(24):7461-4. PubMed ID: 23141915
[TBL] [Abstract][Full Text] [Related]
8. 1,2,4-Triazoloazine derivatives as a new type of herpes simplex virus inhibitors.
Deev SL; Yasko MV; Karpenko IL; Korovina AN; Khandazhinskaya AL; Andronova VL; Galegov GA; Shestakova TS; Ulomskii EN; Rusinov VL; Chupakhin ON; Kukhanova MK
Bioorg Chem; 2010 Dec; 38(6):265-70. PubMed ID: 20947122
[TBL] [Abstract][Full Text] [Related]
9. Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives.
Massari S; Desantis J; Nannetti G; Sabatini S; Tortorella S; Goracci L; Cecchetti V; Loregian A; Tabarrini O
Org Biomol Chem; 2017 Sep; 15(37):7944-7955. PubMed ID: 28902220
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity and Molecular Geometry of Some New Symmetrical Tris(aminoalkyl)amine Derivatives.
Mibu N; Yokomizo K; Murakami K; Ono Y; Ishimaru M; Otsubo M; Inao H; Ono Y; Zhou JR; Sumoto K
Chem Pharm Bull (Tokyo); 2016; 64(12):1769-1780. PubMed ID: 27904085
[TBL] [Abstract][Full Text] [Related]
11. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects.
Abdelkhalek AS; Attia MS; Kamal MA
Curr Med Chem; 2024; 31(14):1896-1919. PubMed ID: 36852819
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral evaluation of 5-(1,2,3-triazol-1-ylmethyl)uridine derivatives.
Abdel-Rahman AA; Wada T
Z Naturforsch C J Biosci; 2009; 64(3-4):163-6. PubMed ID: 19526706
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2.
Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML
Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304
[TBL] [Abstract][Full Text] [Related]
19. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
20. S-7 inhibition of Herpes simplex virus type 1 infectivity and replication in cultured cells.
Muratore O; Pesce-Schito A; Mosti L; Sansebastiano L; Schito GC
J Chemother; 1991 Jan; 3 Suppl 1():84-5. PubMed ID: 12041795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
